| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaxcyte, Inc. (PCVX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 32 sells. PCVX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 496.9K | $25.90M | - | |
| COO | 160.7K | $8.38M | - | |
| CFO | 104.4K | $5.44M | - | |
| Other | 76.0K | $3.96M | - | |
| VP | 29.0K | $1.51M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2021 | Sauer Paul | SVP Process Dev, Manufacturing | Sale+OE | 2,500 | $26.65 | $66,624.36 | -1.6% | |
| Feb 10, 2021 | Hopfner Robert Lorne | Director | Sell | 378,698 | $27.34 | $10,355,466.25 | -2.7% | |
| Feb 3, 2021 | Hopfner Robert Lorne | Director | Sell | 17,002 | $25.12 | $427,066.50 | -0.5% | |
| Jan 28, 2021 | Hopfner Robert Lorne | Director | Sell | 2,000 | $25.07 | $50,140.00 | -0.1% | |
| Jan 27, 2021 | Hopfner Robert Lorne | Director | Sell | 55,254 | $25.62 | $1,415,845.34 | -0.6% | |
| Jan 26, 2021 | Fairman Jeff | VP, Research | Sale+OE | 4,750 | $25.27 | $120,014.50 | -59.4% | |
| Jan 22, 2021 | Hopfner Robert Lorne | Director | Sell | 30,529 | $25.28 | $771,723.38 | -0.5% | |
| Jan 20, 2021 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 3,000 | $25.50 | $76,500.00 | -15.5% | |
| Jan 19, 2021 | Pickering Grant50 | President &CEO | Sale+OE | 15,000 | $25.10 | $376,497.62 | -1.3% | |
| Jan 19, 2021 | Hopfner Robert Lorne | Director | Sell | 91,111 | $25.71 | $2,342,558.10 | -0.9% |